Mad Money Lightning Round OT: Cramer Is A Buyer Of EVR (ALXN, CEPH, GENZ,...
By Benzinga
posted 12:03 04/05/11
| Stocks Analysis Video
 
Font Size
 
Print
 
Sent To A Friend
 
Share
 
follow
 

related articles

from this site

On CNBC's Mad Money Lightning Round OT, Jim Cramer said that Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) reminds him on Cephalon, Inc. (NASDAQ: CEPH), and Genzyme Corporation (NASDAQ: GENZ). It is the company that is doing a lot of good, and it is what this market wants. Cramer would stick with this stock.

Cramer is a buyer of Evercore Partners Inc. (NYSE: EVR). He likes this stock as a M&A play. Evercore Partners Inc. (EVR) added 0.09%, and closed at $34.70.

Cramer is not familiar with Oncolytics Biotech, Inc. (USA) (NASDAQ: ONCY), and he has to do some research, before he makes his call on this stock.

 
 
0
comments
 
0 comments
 
Trade Stocks, Indices, Commodities and Forex - Plus500

add Your comment

 
 
 
 

send to a friend
 

 

Note: Your email address. and that of your recipients, will be used only in the case of transmission errors and to let the recipient who sent the article.
The information will not be used for any other purpose

The Help us prevent spamming, please enter the security code:
Reload Image
 
 

Send a message to: Benzinga
 

 

Note: Your e-mail eddress and that of your recipients, will be used only for the transmission of this content to your recipents.
The information will not be used for any other purpose.

The Help us prevent spamming, please enter the security code:
Reload Image